A low circulating blood level of adiponectin—an adipocytokine, which has both hepatoprotective as well as anti-inflammatory activity—has been reported in NAFLD and T2D [18]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.